GWM
CTLT icon

Geneos Wealth Management’s CATALENT, INC. CTLT Stock Holding History

Geneos Wealth Management’s Portfolio CTLT Stock Details CTLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100
Closed -$11K – 2918
2021
Q2 		$11K Sell
100
-197
-66% -$21.1K ﹤0.01% 2183
2021
Q1 		$33K Hold
297
– – ﹤0.01% 1838
2020
Q4 		$15K Buy
+297
New +$28.8K ﹤0.01% 2066
2017
Q1 		– Sell
-95
Closed -$2K – 2156
2016
Q4 		$2K Hold
95
– – ﹤0.01% 1905
2016
Q3 		$2K Buy
+95
New +$2.36K ﹤0.01% 1824

Other funds holding CTLT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geneos Wealth Management's CTLT Position: Q3 2021 in Review

Geneos Wealth Management sold out of CATALENT, INC. (CTLT) in Q3 2021, closing a stake of 100 shares — an estimated $11K sold.

Geneos Wealth Management first reported a position in CTLT in Q3 2016 and held it in 5 quarters. The position peaked at $33K in Q1 2021. 529 funds tracked by Wall St. Rank hold CTLT as of Q3 2021.

  • Geneos Wealth Management reported no remaining CATALENT, INC. position as of Q3 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 100 CATALENT, INC. shares in Q3 2021, an estimated $11K.
  • Geneos Wealth Management first reported a position in CATALENT, INC. in Q3 2016 and held it in 5 quarters.
  • Geneos Wealth Management's CATALENT, INC. position peaked at $33K in Q1 2021.
  • 529 funds tracked by Wall St. Rank held CATALENT, INC. as of Q3 2021.

Based on Geneos Wealth Management's 13F filing for Q3 2021, filed 9 Nov 2021.